Andrew Elzinga

Cornerstone Research

Associate

Boston, MA 02115

United States

SCHOLARLY PAPERS

1

DOWNLOADS

23

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (1)

1.

One Year after the Launch of the First U.S. Biosimilar Drug: Lessons for the Future?

Number of pages: 28 Posted: 09 Aug 2017
Duke University - Department of Economics, Cornerstone Research - Boston Office, Cornerstone Research and Cornerstone Research
Downloads 23 (548,539)

Abstract:

Loading...

Biologic, Biosimilar, Drug Competition